ArticleOncotarget2015

The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma.

Hongping Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.